Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Frequently asked questions
What sector does Elixxer Ltd (ELXR) operate in?
Elixxer Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Elixxer Ltd (ELXR) current stock price?
As of the latest data, Elixxer Ltd stock price is CA$0.03, with a previous close of CA$0.03.
What is Elixxer Ltd (ELXR) current market capitalization?
Elixxer Ltd market cap is approximately 13.05 million.
What is Elixxer Ltd (ELXR) Earnings Per Share (EPS)?
The trailing EPS is -CA$1.02.
Does Elixxer Ltd (ELXR) pay dividends?
No. Elixxer Ltd does not pay a dividend.
When is Elixxer Ltd (ELXR) next earnings report?
Elixxer Ltd is expected to release its next earnings report on June 30, 2026.
What is Elixxer Ltd (ELXR) beta (volatility) score?
Elixxer Ltd has a beta of 0.872, meaning its volatility is roughly in line with the market.